Dr. Ian Bird to Chair NIH Study
Published: 2/3/2012

Ian Bird, PhD
Dr. Ian Bird has been asked to chair the February NIH Study section reviewing applications in translational and clinical research as well as clinical trials that will advance our knowledge about the underlying mechanisms of drug action, response, and safety in children at various developmental stages, and/or in pregnant women and the developing fetus. The overall goals of the initiative are to improve the safety and effectiveness of current drugs for pediatric or obstetric patients, and to enhance the development of new drugs or a safer usage of the existing drugs for tailored therapies to meet emerging clinical needs for these special populations.